Ocera Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 73   

Articles published

OCRX 2.64 +0.03 (1.15%)
price chart
Ocera Therapeutics Announces Completion of Merger With Tranzyme
SAN DIEGO, July 15, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. ("Ocera"), a clinical stage biopharmaceutical company developing novel therapeutics for orphan liver diseases, and Tranzyme, Inc. (Nasdaq:TZYM) ("Tranzyme") today announced ...
Related articles »  
Trading the Biotech News: Ocera Therapeutics, Inc. (NASDAQ:OCRX), Amicus ...
Ocera Therapeutics, Inc. (NASDAQ:OCRX) added 9.17% by the close of business day at $2.62. For the current quarter, the 3 Wall Street analysts issuing adjusted earnings per share outlook have a consensus estimate of -$0.33/share, which would compare ...
Ocera Therapeutics' (OCRX) "Buy" Rating Reiterated at JMP Securities
Ocera Therapeutics Inc. (NASDAQ:OCRX)'s stock had its “buy” rating reissued by stock analysts at JMP Securities in a note issued to investors on Thursday.
Top Gainers: Galectin Therapeutics, Inc. (NASDAQ:GALT), Ocera Therapeutics ...  Benchmark Monitor
Brokers Update Target Prices On Ocera Therapeutics, Inc. (OCRX)  Fiscal Standard
Ocera Therapeutics Finally Ready To Reward Investors
Furthermore, to bluntly state the obvious, Ocera has had a rough 2014. Investors unfamiliar with the company would probably look at the stock chart and move on to the next assuming that something catastrophic had occurred to warrant such a steep price ...
Ocera Therapeutics Inc. (OCRX) Given "Buy" Rating at JMP Securities
Ocera Therapeutics Inc. logo JMP Securities reissued their buy rating on shares of Ocera Therapeutics Inc. (NASDAQ:OCRX) in a report published on Thursday.
Ocera Therapeutics, Inc. (NASDAQ:OCRX) completes enrollment in STOP-ALF ...  Benchmark Monitor
One Stock Analysts Are Watching - Ocera Therapeutics, Inc. (OCRX)  FTSE News
Ocera Therapeutics Inc (NASDAQ:OCRX) Stock Technicals at Critical Inflection Point
This is a technical analysis stock rating for Ocera Therapeutics Inc (NASDAQ:OCRX) . The company has a three bull technical rating which indicates an inflection point.
Catching the Wonder of Investors: Ocera Therapeutics, Inc. (NASDAQ:OCRX)
Curious Investors have been seeking information about shares of Ocera Therapeutics, Inc. (NASDAQ:OCRX) after the stock moved 1.53%, hitting the $2.65 price point following a recent trade.
Will Ocera Therapeutics, Inc. (NASDAQ:OCRX) Meet or Beat Earnings This Quarter ...
Analysts are predicting that Ocera Therapeutics, Inc. (NASDAQ:OCRX) is going to report an earnings of $-0.36 per share.
FY2016 EPS Estimates for Ocera Therapeutics Inc. (OCRX) Boosted by Analyst
Ocera Therapeutics logo Ocera Therapeutics Inc. (NASDAQ:OCRX) - Equities research analysts at Brean Capital raised their FY2016 earnings per share estimates for Ocera Therapeutics in a report released on Tuesday.
Ocera Therapeutics, Inc. (OCRX) Updated Broker Price Targets
Market analysts have recently updated their ratings and price targets on shares of Ocera Therapeutics, Inc. (OCRX). The latest reports which are currently in issue on Thursday 29th of September state 0 analysts have a rating of “strong buy”, 0 analysts ...